Clinical trial Recruiting at 1 site Observational Ages 65 and up

Examining heart blood flow in patients with severe aortic valve narrowing

Official title: Correlation of FFR and iFR With Cardiac PET Perfusion (at Rest and Under Adenosine) in the Evaluation of Intermediate Coronary Stenoses in Patients With Severe Aortic Valve Stenosis

Run by Heart and Diabetes Center North-Rhine Westfalia · NCT04882488 · Data updated 2026-11-12

This study tests how two heart flow measurements can help doctors understand and treat patients with severe aortic valve narrowing and coronary artery disease.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment20 (estimated)
SponsorHeart and Diabetes Center North-Rhine Westfalia
Academic / other
Locations1 site (Bad Oeynhausen, North Rhine-Westphalia)
StatusRecruiting
StartedJune 1, 2021
Main results expectedJune 30, 2025
Study endsSeptember 30, 2025
Registry record updatedNovember 26, 2024
Trial IDNCT04882488 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients over 65 years old with severe aortic stenosis and a left ventricular ejection fraction greater than 55%.

Probably not a fit

Patients who have a left ventricular ejection fraction below 55% or intolerance to adenosine may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) with cardiac PET perfusion imaging in patients suffering from severe aortic valve stenosis. The study aims to understand how these measurements correlate with coronary artery disease, which is common in patients with aortic stenosis. By evaluating patients who are eligible for transcatheter aortic valve replacement, the study seeks to determine the effectiveness of FFR and iFR in assessing coronary flow reserve and guiding treatment decisions. The findings could help improve the management of patients with concurrent aortic stenosis and coronary artery disease.

Why it matters

Potential benefit: If successful, this study could enhance the accuracy of diagnosing and treating coronary artery disease in patients with severe aortic valve stenosis.

How similar studies have gone: Other studies have shown promising correlations between FFR, iFR, and myocardial perfusion imaging in similar patient populations, suggesting that this approach is supported by existing research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients with severe aortic Stenosis eligible for transcatheter aortic stenosis
* left ventricular ejection fraction \> 55%
* no intolerance of Adenosin
* no history of bradycardia, atrioventricular Blockade
* intermediate coronary Stenosis with FFR\> 0.8
* Age \>65

Exclusion Criteria:

* intolerance of Adenosin
* left ventricular ejection fraction \< 55%

Where it's running

  • Herz- und Diabeteszentrum, NRW
    Bad Oeynhausen, North Rhine-Westphalia, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.